Holliston, Mass.-based biotechnology company Biostage Inc. elected Wei Zhang to its board.
Zhang is a professor of innovation at Peking University in Beijing. At Peking University, Zhang headed business strategy programs for clients such as Johnson & Johnson and Novartis AG, among others, Biostage said in a statement.
Zhang is expected to help the company expand its programs in China.
Biostage is developing bioengineered organ implants to treat life-threatening conditions.
